John T. Vilade - 10 Feb 2026 Form 4 Insider Report for CuriosityStream Inc. (CURI)

Reporting relationship: Chief Commercial Officer
Issuer ticker: CURI
Reported as of: 10 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Feb 2026, 17:07:04 UTC
Prior SEC filing: 10 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ P. Brady Hayden as attorney-in-fact for John T. Vilade

Key filing fact

John T. Vilade filed Form 4 for CuriosityStream Inc. (CURI) on 12 Feb 2026.

Key facts

This page summarizes John T. Vilade's Form 4 filing for CuriosityStream Inc. (CURI).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Feb 2026, 17:07.

Change

Previous filing in this sequence was filed on 10 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002110455 Primary reporting owner

Vilade John Thomas Jr

Relationship: Chief Commercial Officer
Address: 8484 GEORGIA AVENUE, SUITE 700, SILVER SPRING, MD
Signature: /s/ P. Brady Hayden as attorney-in-fact for John T. Vilade
Signature date: 12 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CURI transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 10 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price
Footnotes: F1, F2

CURI transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 10 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On February 10, 2026, the Company granted Mr. Vilade 150,000 restricted stock units (RSUs) with tandem dividend equivalent rights under the Company's 2020 Omnibus Incentive Plan. The RSUs granted will vest in four tranches of 37,500 each upon the date the Board of Directors determines that the applicable performance condition has been achieved: (i) the Company's common stock achieves a 10-day Volume Weighted Average Price (VWAP) of $6.50 or achievement of 2026 Company annual bonus plan targets (at 100%); (ii) the common stock achieves a 10-day VWAP of $7.50 or achievement of 2027 Company annual bonus plan targets (at 100%); (iii) the common stock achieves a 10-day VWAP of $9.50 or achievement of 2028 Company annual bonus plan targets (at 100%); and (iv) the common stock achieves a 10-day VWAP of $11.50 or achievement of 2029 Company annual bonus plan targets (at 100%). Any RSUs not earned by January 31, 2030, will be cancelled.

Footnote F2

Each RSU represents the right to receive one share of common stock and will be settled upon vesting (or within 30 days thereafter). All vesting events are subject to continued employment on each applicable vesting date.

Footnote F3

On February 10, 2026, the Company granted Mr. Vilade 100,000 RSUs with tandem dividend equivalent rights under the Company's 2020 Omnibus Incentive Plan. The RSUs will vest in four tranches of 25,000 each on the first, second, third and fourth anniversaries of the grant date.

SEC remarks

Exhibit 24, Power of Attorney, is attached